Global Arsenic Trioxide Injection Market Size To Worth USD 2346.05 Million By 2033 | CAGR Of 4.62%
Category: HealthcareGlobal Arsenic Trioxide Injection Market Size To Worth USD 2346.05 Million By 2033
According to a research report published by Spherical Insights & Consulting, The Global Arsenic Trioxide Injection Market Size is Expected to Grow from USD 1492.77 Million in 2023 to USD 2346.05 Million By 2033, at a CAGR of 4.62% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 189 pages with 119 Market data tables and figures & charts from the report on the "Global Arsenic Trioxide Injection Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Multi-Dose Vials and Single-Dose Vials), By Indication (Solid Tumor, Acute Promyelocytic Leukemia, and Others), By Distribution Channel (Online Pharmacies, Specialty Clinics, Hospitals, and Retail Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/arsenic-trioxide-injection-market
The arsenic trioxide injection market is a pharmaceutical industry focused on developing, producing, and distributing arsenic trioxide injections for managing acute promyelocytic leukemia (APL), a low-risk blood cell malignancy. It can also be used for various types of cancer and in patients who have not responded to previous therapies. Arsenic trioxide inhibits cancer cell proliferation and is classified as an antineoplastic. The rising prevalence of APL in the United States, with 5-10% of child cases of AML being APL, has led to increased demand for these injections. The market is growing due to its effectiveness in treating APL, advancements in pharmaceutical formulations, investments in oncology research, and government initiatives. The widespread adoption in developed and developing regions drives the market growth. However, stringent regulatory guidelines may impede market growth.
The single-dose vials segment held the greatest share in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the product type, the global arsenic trioxide injection market is categorized as multi-dose vials and single-dose vials. Among these, the single-dose vials segment held the greatest share in 2023 and is predicted to grow at a significant CAGR during the predicted period. Segmental expansion is driven by reduced contamination risk, precision dose, enhanced vaccine safety, prefilled features, reduced medication waste, ease of monitoring, and patient compliance.
The acute promyelocytic leukemia segment accounted for the highest share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the indication, the global arsenic trioxide injection market is categorized as solid tumor, acute promyelocytic leukemia, and others. Among these, the acute promyelocytic leukemia segment accounted for the highest share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The growth of the segment is attributed to the superior efficacy, safety, and rapid onset of arsenic trioxide injections in managing acute promyelocytic leukemia, as well as their increasing prevalence and effectiveness in first-line treatment.
The hospitals segment accounted for the highest share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the distribution channel, the global arsenic trioxide injection market is categorized as online pharmacies, specialty clinics, hospitals, and retail pharmacies. Among these, the hospitals segment accounted for the highest share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The growth of the segment is driven by increased emergency care unit and comprehensive care patient admissions, the need for skilled personnel in hospitals for intravenous arsenic trioxide administration, advanced facilities, personalized treatment, and an increase in leukemia prevalence, leading to growth in in-patient department services.
North America is expected to hold the greatest share of the global arsenic trioxide injection market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global arsenic trioxide injection market over the forecast period. The rise in oncological research is attributed to increased investments, regulatory approvals, technological innovations, molecular study research, rising blood cancer prevalence, increased awareness of chronic diseases, industrial expansion, and favorable government policies, along with increased awareness and treatment of chronic diseases among the population.
Asia Pacific is predicted to hold the fastest-growing region of the global arsenic trioxide injection market throughout the estimated period. This is driven by a growing patient population, increased awareness of treatment alternatives, and increased healthcare investments, particularly in China, India, and Japan, which are bolstered by government programs enhancing healthcare accessibility and affordability.
Major key players in the global arsenic trioxide injection market are China National Gold Group Corporation, Teva Pharmaceuticals, Intas Pharmaceuticals, GLS Pharma, Hunan Gold Group, Dundee Precious Metal Tsumeb, Managem Mining Group, Sintetica, Zydus Pharmaceuticals, Evestar Healthcare, Amneal Pharmaceuticals, and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In September 2021, Amneal Pharmaceuticals has launched Arsenic Trioxide Injection, a generic equivalent of Trisenox, approved by the FDA for use in patients with advanced prostate cancer (APL) who have relapsed from retinoid and anthracycline chemotherapy and have APL characterized by the t (15;17) translocation or PML/RAR-alpha gene expression.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global arsenic trioxide injection market based on the below-mentioned segments:
Global Arsenic Trioxide Injection Market, By Product Type
- Multi-Dose Vials
- Single-Dose Vials
Global Arsenic Trioxide Injection Market, By Indication
- Solid Tumor
- Acute Promyelocytic Leukemia
- Others
Global Arsenic Trioxide Injection Market, By Distribution Channel
- Online Pharmacies
- Specialty Clinics
- Hospitals
- Retail Pharmacies
Global Arsenic Trioxide Injection Market, By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?